| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,212 | 25,172 | 25,194 | 25,830 | | Cost of Revenue | 4,333 | 4,490 | 4,936 | 5,198 | | | Gross Profit |
-
| 20,682 | 20,258 | 20,632 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,292 | 7,143 | 6,120 | 5,718 | | Non Recurring | (251) | 251 |
-
|
-
| | Others | 602 | (56) | 579 | 2,101 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 13,344 | 13,559 | 12,813 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 13,236 | 13,344 | 13,559 | 12,729 | | Interest Expense | 8,808 | 9,427 | 9,925 | 10,712 | | Income Before Tax | 4,428 | 3,917 | 3,634 | 2,017 | | Income Tax Expense | 848 | 697 | 597 | 42 | | Minority Interest | (74) | (99) |
-
| (84) | | | | Net Income From Continuing Ops | 3,506 | 3,121 | 3,037 | 1,975 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,506 | 3,121 | 3,037 | 1,975 | | Preferred Stock And Other Adjustments |
-
| 5 | (5) |
-
| | | Net Income Applicable To Common Shares | $3,506 | $3,126 | $3,032 | $1,975 |
|
0.22% Nasdaq 
Income Statement
